RNA Assays for Endometriosis Detection and Diagnosis

Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.

NCT Number	NCT06907303
Lead Sponsor	Wren Laboratories LLC Collaborators: University of Cape Town
Conditions	Endometriosis
Enrollment	400 participants
Start Date	2024-01-01
Primary Completion	2025-08-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-02